Loading…
Relationship between LAAM-methadone preference and treatment outcomes
Studies of relative LAAM-methadone preference have indicated that a significant proportion of patients prefer levo-alpha-acetylmethadol (LAAM). The present study was designed to determine whether this preference is associated with better treatment outcomes. Sixty-two stable methadone patients partic...
Saved in:
Published in: | Drug and alcohol dependence 2002-05, Vol.66 (3), p.295-301 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c366t-3e795846fe706b368722f3cdd092a16c933b4499712da1a3d6f48849efb7a3763 |
---|---|
cites | cdi_FETCH-LOGICAL-c366t-3e795846fe706b368722f3cdd092a16c933b4499712da1a3d6f48849efb7a3763 |
container_end_page | 301 |
container_issue | 3 |
container_start_page | 295 |
container_title | Drug and alcohol dependence |
container_volume | 66 |
creator | WHITE, Jason M DANZ, Cath KNEEBONE, Joanne LA VINCENTE, Sophie F NEWCOMBE, David A. L ALI, Robert L |
description | Studies of relative LAAM-methadone preference have indicated that a significant proportion of patients prefer levo-alpha-acetylmethadol (LAAM). The present study was designed to determine whether this preference is associated with better treatment outcomes. Sixty-two stable methadone patients participated in a randomised crossover clinical trial. They received LAAM (alternate days) and methadone (daily) for 3 months each, followed by a further 6-month period during which they were free to choose between the drugs. LAAM maintenance was associated with a lower rate of heroin use than methadone maintenance based on analysis of morphine concentration in hair and equivalent health outcomes. The majority of subjects showed a preference for LAAM (n=27, 69.2%) rather than methadone (n=12, 30.8%). The main reasons given for the LAAM preference were that it produced less withdrawal (39.3%), fewer side effects (28.5%), less craving for heroin (17.9%), and entailed fewer pick-up days (14.3%). Those who chose LAAM had lower levels of heroin use during LAAM maintenance, significantly better outcomes on two sub-scales of the SF-36 (Vitality and Mental Health), and reported that they felt more normal and that they were 'held' better when on LAAM. For those who chose methadone, there were no differences in outcomes between the LAAM and methadone maintenance periods. Preference for LAAM is associated with treatment outcomes as good or better than those with methadone. |
doi_str_mv | 10.1016/S0376-8716(02)00007-8 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_57857503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>57857503</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-3e795846fe706b368722f3cdd092a16c933b4499712da1a3d6f48849efb7a3763</originalsourceid><addsrcrecordid>eNpFkMlOwzAQhi0EoqXwCKBcQHAIeEm8HKuqLFIREsvZcpyJGpQ4JXaEeHvcNoK5zOX7Z_kQOif4lmDC794wEzyVgvBrTG9wLJHKAzQlUqgU44wfoukfMkEn3n9uIa7wMZoQijnNeDZFy1doTKg759f1JikgfAO4ZDWfP6cthLUpOwfJpocKenAWEuPKJPRgQgsuJN0QbNeCP0VHlWk8nI19hj7ul--Lx3T18vC0mK9SyzgPKQOhcpnxCgTmBeNSUFoxW5ZYUUO4VYwVWaaUILQ0xLCSV5mUmYKqECb-wmboaj9303dfA_ig29pbaBrjoBu8zoXMRY5ZBPM9aPvO-3i-3vR1a_ofTbDe-tM7f3orR2Oqd_60jLmLccFQtFD-p0ZhEbgcAeOtaareOFv7f47xODYe8AsAc3eB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>57857503</pqid></control><display><type>article</type><title>Relationship between LAAM-methadone preference and treatment outcomes</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>ScienceDirect Freedom Collection 2022-2024</source><source>ScienceDirect®</source><creator>WHITE, Jason M ; DANZ, Cath ; KNEEBONE, Joanne ; LA VINCENTE, Sophie F ; NEWCOMBE, David A. L ; ALI, Robert L</creator><creatorcontrib>WHITE, Jason M ; DANZ, Cath ; KNEEBONE, Joanne ; LA VINCENTE, Sophie F ; NEWCOMBE, David A. L ; ALI, Robert L</creatorcontrib><description>Studies of relative LAAM-methadone preference have indicated that a significant proportion of patients prefer levo-alpha-acetylmethadol (LAAM). The present study was designed to determine whether this preference is associated with better treatment outcomes. Sixty-two stable methadone patients participated in a randomised crossover clinical trial. They received LAAM (alternate days) and methadone (daily) for 3 months each, followed by a further 6-month period during which they were free to choose between the drugs. LAAM maintenance was associated with a lower rate of heroin use than methadone maintenance based on analysis of morphine concentration in hair and equivalent health outcomes. The majority of subjects showed a preference for LAAM (n=27, 69.2%) rather than methadone (n=12, 30.8%). The main reasons given for the LAAM preference were that it produced less withdrawal (39.3%), fewer side effects (28.5%), less craving for heroin (17.9%), and entailed fewer pick-up days (14.3%). Those who chose LAAM had lower levels of heroin use during LAAM maintenance, significantly better outcomes on two sub-scales of the SF-36 (Vitality and Mental Health), and reported that they felt more normal and that they were 'held' better when on LAAM. For those who chose methadone, there were no differences in outcomes between the LAAM and methadone maintenance periods. Preference for LAAM is associated with treatment outcomes as good or better than those with methadone.</description><identifier>ISSN: 0376-8716</identifier><identifier>EISSN: 1879-0046</identifier><identifier>DOI: 10.1016/S0376-8716(02)00007-8</identifier><identifier>PMID: 12062464</identifier><identifier>CODEN: DADEDV</identifier><language>eng</language><publisher>Shannon: Elsevier Science</publisher><subject>Adult ; Australia ; Biological and medical sciences ; Chi-Square Distribution ; Cross-Over Studies ; Drug addictions ; Drug addicts ; Female ; Heroin ; Heroin Dependence - drug therapy ; Heroin Dependence - rehabilitation ; Humans ; Levo-alpha-acetylmethadol ; Male ; Medical sciences ; Methadone ; Methadone - therapeutic use ; Methadyl Acetate - therapeutic use ; Middle Aged ; Narcotics - therapeutic use ; Outcomes ; Patient Satisfaction - statistics & numerical data ; Preferences ; Statistics, Nonparametric ; Toxicology ; Treatment ; Treatment Outcome</subject><ispartof>Drug and alcohol dependence, 2002-05, Vol.66 (3), p.295-301</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-3e795846fe706b368722f3cdd092a16c933b4499712da1a3d6f48849efb7a3763</citedby><cites>FETCH-LOGICAL-c366t-3e795846fe706b368722f3cdd092a16c933b4499712da1a3d6f48849efb7a3763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924,30999</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13637603$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12062464$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WHITE, Jason M</creatorcontrib><creatorcontrib>DANZ, Cath</creatorcontrib><creatorcontrib>KNEEBONE, Joanne</creatorcontrib><creatorcontrib>LA VINCENTE, Sophie F</creatorcontrib><creatorcontrib>NEWCOMBE, David A. L</creatorcontrib><creatorcontrib>ALI, Robert L</creatorcontrib><title>Relationship between LAAM-methadone preference and treatment outcomes</title><title>Drug and alcohol dependence</title><addtitle>Drug Alcohol Depend</addtitle><description>Studies of relative LAAM-methadone preference have indicated that a significant proportion of patients prefer levo-alpha-acetylmethadol (LAAM). The present study was designed to determine whether this preference is associated with better treatment outcomes. Sixty-two stable methadone patients participated in a randomised crossover clinical trial. They received LAAM (alternate days) and methadone (daily) for 3 months each, followed by a further 6-month period during which they were free to choose between the drugs. LAAM maintenance was associated with a lower rate of heroin use than methadone maintenance based on analysis of morphine concentration in hair and equivalent health outcomes. The majority of subjects showed a preference for LAAM (n=27, 69.2%) rather than methadone (n=12, 30.8%). The main reasons given for the LAAM preference were that it produced less withdrawal (39.3%), fewer side effects (28.5%), less craving for heroin (17.9%), and entailed fewer pick-up days (14.3%). Those who chose LAAM had lower levels of heroin use during LAAM maintenance, significantly better outcomes on two sub-scales of the SF-36 (Vitality and Mental Health), and reported that they felt more normal and that they were 'held' better when on LAAM. For those who chose methadone, there were no differences in outcomes between the LAAM and methadone maintenance periods. Preference for LAAM is associated with treatment outcomes as good or better than those with methadone.</description><subject>Adult</subject><subject>Australia</subject><subject>Biological and medical sciences</subject><subject>Chi-Square Distribution</subject><subject>Cross-Over Studies</subject><subject>Drug addictions</subject><subject>Drug addicts</subject><subject>Female</subject><subject>Heroin</subject><subject>Heroin Dependence - drug therapy</subject><subject>Heroin Dependence - rehabilitation</subject><subject>Humans</subject><subject>Levo-alpha-acetylmethadol</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methadone</subject><subject>Methadone - therapeutic use</subject><subject>Methadyl Acetate - therapeutic use</subject><subject>Middle Aged</subject><subject>Narcotics - therapeutic use</subject><subject>Outcomes</subject><subject>Patient Satisfaction - statistics & numerical data</subject><subject>Preferences</subject><subject>Statistics, Nonparametric</subject><subject>Toxicology</subject><subject>Treatment</subject><subject>Treatment Outcome</subject><issn>0376-8716</issn><issn>1879-0046</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNpFkMlOwzAQhi0EoqXwCKBcQHAIeEm8HKuqLFIREsvZcpyJGpQ4JXaEeHvcNoK5zOX7Z_kQOif4lmDC794wEzyVgvBrTG9wLJHKAzQlUqgU44wfoukfMkEn3n9uIa7wMZoQijnNeDZFy1doTKg759f1JikgfAO4ZDWfP6cthLUpOwfJpocKenAWEuPKJPRgQgsuJN0QbNeCP0VHlWk8nI19hj7ul--Lx3T18vC0mK9SyzgPKQOhcpnxCgTmBeNSUFoxW5ZYUUO4VYwVWaaUILQ0xLCSV5mUmYKqECb-wmboaj9303dfA_ig29pbaBrjoBu8zoXMRY5ZBPM9aPvO-3i-3vR1a_ofTbDe-tM7f3orR2Oqd_60jLmLccFQtFD-p0ZhEbgcAeOtaareOFv7f47xODYe8AsAc3eB</recordid><startdate>20020501</startdate><enddate>20020501</enddate><creator>WHITE, Jason M</creator><creator>DANZ, Cath</creator><creator>KNEEBONE, Joanne</creator><creator>LA VINCENTE, Sophie F</creator><creator>NEWCOMBE, David A. L</creator><creator>ALI, Robert L</creator><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope></search><sort><creationdate>20020501</creationdate><title>Relationship between LAAM-methadone preference and treatment outcomes</title><author>WHITE, Jason M ; DANZ, Cath ; KNEEBONE, Joanne ; LA VINCENTE, Sophie F ; NEWCOMBE, David A. L ; ALI, Robert L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-3e795846fe706b368722f3cdd092a16c933b4499712da1a3d6f48849efb7a3763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Australia</topic><topic>Biological and medical sciences</topic><topic>Chi-Square Distribution</topic><topic>Cross-Over Studies</topic><topic>Drug addictions</topic><topic>Drug addicts</topic><topic>Female</topic><topic>Heroin</topic><topic>Heroin Dependence - drug therapy</topic><topic>Heroin Dependence - rehabilitation</topic><topic>Humans</topic><topic>Levo-alpha-acetylmethadol</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methadone</topic><topic>Methadone - therapeutic use</topic><topic>Methadyl Acetate - therapeutic use</topic><topic>Middle Aged</topic><topic>Narcotics - therapeutic use</topic><topic>Outcomes</topic><topic>Patient Satisfaction - statistics & numerical data</topic><topic>Preferences</topic><topic>Statistics, Nonparametric</topic><topic>Toxicology</topic><topic>Treatment</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WHITE, Jason M</creatorcontrib><creatorcontrib>DANZ, Cath</creatorcontrib><creatorcontrib>KNEEBONE, Joanne</creatorcontrib><creatorcontrib>LA VINCENTE, Sophie F</creatorcontrib><creatorcontrib>NEWCOMBE, David A. L</creatorcontrib><creatorcontrib>ALI, Robert L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><jtitle>Drug and alcohol dependence</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WHITE, Jason M</au><au>DANZ, Cath</au><au>KNEEBONE, Joanne</au><au>LA VINCENTE, Sophie F</au><au>NEWCOMBE, David A. L</au><au>ALI, Robert L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship between LAAM-methadone preference and treatment outcomes</atitle><jtitle>Drug and alcohol dependence</jtitle><addtitle>Drug Alcohol Depend</addtitle><date>2002-05-01</date><risdate>2002</risdate><volume>66</volume><issue>3</issue><spage>295</spage><epage>301</epage><pages>295-301</pages><issn>0376-8716</issn><eissn>1879-0046</eissn><coden>DADEDV</coden><abstract>Studies of relative LAAM-methadone preference have indicated that a significant proportion of patients prefer levo-alpha-acetylmethadol (LAAM). The present study was designed to determine whether this preference is associated with better treatment outcomes. Sixty-two stable methadone patients participated in a randomised crossover clinical trial. They received LAAM (alternate days) and methadone (daily) for 3 months each, followed by a further 6-month period during which they were free to choose between the drugs. LAAM maintenance was associated with a lower rate of heroin use than methadone maintenance based on analysis of morphine concentration in hair and equivalent health outcomes. The majority of subjects showed a preference for LAAM (n=27, 69.2%) rather than methadone (n=12, 30.8%). The main reasons given for the LAAM preference were that it produced less withdrawal (39.3%), fewer side effects (28.5%), less craving for heroin (17.9%), and entailed fewer pick-up days (14.3%). Those who chose LAAM had lower levels of heroin use during LAAM maintenance, significantly better outcomes on two sub-scales of the SF-36 (Vitality and Mental Health), and reported that they felt more normal and that they were 'held' better when on LAAM. For those who chose methadone, there were no differences in outcomes between the LAAM and methadone maintenance periods. Preference for LAAM is associated with treatment outcomes as good or better than those with methadone.</abstract><cop>Shannon</cop><pub>Elsevier Science</pub><pmid>12062464</pmid><doi>10.1016/S0376-8716(02)00007-8</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0376-8716 |
ispartof | Drug and alcohol dependence, 2002-05, Vol.66 (3), p.295-301 |
issn | 0376-8716 1879-0046 |
language | eng |
recordid | cdi_proquest_miscellaneous_57857503 |
source | Applied Social Sciences Index & Abstracts (ASSIA); ScienceDirect Freedom Collection 2022-2024; ScienceDirect® |
subjects | Adult Australia Biological and medical sciences Chi-Square Distribution Cross-Over Studies Drug addictions Drug addicts Female Heroin Heroin Dependence - drug therapy Heroin Dependence - rehabilitation Humans Levo-alpha-acetylmethadol Male Medical sciences Methadone Methadone - therapeutic use Methadyl Acetate - therapeutic use Middle Aged Narcotics - therapeutic use Outcomes Patient Satisfaction - statistics & numerical data Preferences Statistics, Nonparametric Toxicology Treatment Treatment Outcome |
title | Relationship between LAAM-methadone preference and treatment outcomes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T06%3A51%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20between%20LAAM-methadone%20preference%20and%20treatment%20outcomes&rft.jtitle=Drug%20and%20alcohol%20dependence&rft.au=WHITE,%20Jason%20M&rft.date=2002-05-01&rft.volume=66&rft.issue=3&rft.spage=295&rft.epage=301&rft.pages=295-301&rft.issn=0376-8716&rft.eissn=1879-0046&rft.coden=DADEDV&rft_id=info:doi/10.1016/S0376-8716(02)00007-8&rft_dat=%3Cproquest_cross%3E57857503%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c366t-3e795846fe706b368722f3cdd092a16c933b4499712da1a3d6f48849efb7a3763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=57857503&rft_id=info:pmid/12062464&rfr_iscdi=true |